Pharmaceutical company settles civil allegations for $2.8M
Published: March 29,2012
MADISON — A Mississippi-based pharmaceutical company has agreed to pay $2.8 million to resolve civil allegations that the manufacturer falsely marketed skin products to receive government funding.
U.S. Attorney John M. Bales said yesterday Cypress Pharmaceutical Inc., a subsidiary and CEO Max Draughn will pay $1.6 million to the military’s TRICARE program and $1.2 million to state Medicaid programs.
The government alleges that Cypress subsidiary Hawthorne Pharmaceuticals Inc. claimed that three skin products carried the Food and Drug Administration’s “safe and effective” designation when the treatments didn’t. The government also claims the regulatory status of the products was misrepresented.
Bales says a whistleblower who sued under the False Claims Act received $300,000 as part of the settlement.
An official for Madison-based Cypress didn’t immediately return a phone call seeking comment.
To sign up for Mississippi Business Daily Updates, click here.
FOLLOW THE MBJ ON TWITTERMy Tweets
Top Posts & Pages
- NEW IN MADISON COUNTY — Mississippi Bio-Medical Business Collaboratory to be introduced Friday
- GreenTech holds grand opening of neighborhood electric vehicle plant
- Alcorn president launches new customer service task force
- Turner Grain’s bankruptcy will help consolidate lawsuits alleging breach of contract
- David Duval, former British Open winner, joins Sanderson Farms field
- Mississippi Film Studios signs contract with New Orleans company
- Court rules against Greenwood councilwoman; must give up office
- MDOT cutting more than 40 jobs in Right-of-Way Division
- Mars Food expanding Delta plant; investing $31M and adding jobs